{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T11:36:18Z","timestamp":1772969778227,"version":"3.50.1"},"reference-count":37,"publisher":"Japanese Society of Internal Medicine","issue":"17","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2020,9,1]]},"DOI":"10.2169\/internalmedicine.4628-20","type":"journal-article","created":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T22:09:50Z","timestamp":1598911790000},"page":"2089-2094","source":"Crossref","is-referenced-by-count":14,"title":["Exploratory Research on the Relationship between Human Gut Microbiota and Portal Hypertension"],"prefix":"10.2169","volume":"59","author":[{"given":"Keiji","family":"Yokoyama","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Medicine, Fukuoka University Faculty of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoaki","family":"Tsuchiya","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Medicine, Fukuoka University Faculty of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Yamauchi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Medicine, Fukuoka University Faculty of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Miyayama","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Medicine, Fukuoka University Faculty of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yotaro","family":"Uchida","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Medicine, Fukuoka University Faculty of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kumiko","family":"Shibata","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Medicine, Fukuoka University Faculty of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromi","family":"Fukuda","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Medicine, Fukuoka University Faculty of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaoru","family":"Umeda","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Medicine, Fukuoka University Faculty of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhide","family":"Takata","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Medicine, Fukuoka University Faculty of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Medicine, Fukuoka University Faculty of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinjiro","family":"Inomata","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Medicine, Fukuoka University Faculty of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Morihara","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Medicine, Fukuoka University Faculty of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuaki","family":"Takeyama","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Medicine, Fukuoka University Faculty of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Shakado","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Medicine, Fukuoka University Faculty of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shotaro","family":"Sakisaka","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Medicine, Fukuoka University Faculty of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumihito","family":"Hirai","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Medicine, Fukuoka University Faculty of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Bellot P, Franc\u00e9s R, Such J. Pathological bacterial translocation in cirrhosis: pathophysiology, diagnosis and clinical implications. Liver Int 33: 31-39, 2013."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Guarner C, Soriano G. Bacterial translocation and its consequences in patients with cirrhosis. Eur J Gastroenterol Hepatol 17: 27-31, 2005.","DOI":"10.1097\/00042737-200501000-00006"},{"key":"3","unstructured":"3. Giannelli V, Di Gregorio V, Iebba V, et al. Microbiota and the gut-liver axis: bacterial translocation, inflammation and infection in cirrhosis. World J Gastroenterol 20: 16795-16810, 2014."},{"key":"4","doi-asserted-by":"crossref","first-page":"441","DOI":"10.4161\/gmic.29599","volume":"5","author":"C Roderburg","year":"2014","unstructured":"4. Roderburg C, Luedde T. The role of the gut microbiome in the development and progression of liver cirrhosis and hepatocellular carcinoma. Gut Microbes 5: 441-445, 2014.","journal-title":"Gut Microbes","ISSN":"https:\/\/id.crossref.org\/issn\/1949-0976","issn-type":"print"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Liu WT, Marsh TL, Cheng H, Forney LJ. Characterization of microbial diversity by determining terminal restriction fragment length polymorphisms of genes encoding 16S rRNA. Appl Environ Microbiol 63: 4516-4522, 1997.","DOI":"10.1128\/AEM.63.11.4516-4522.1997"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Wiest R, Lawson M, Geuking M. Pathological bacterial translocation in liver cirrhosis. J Hepatol 60: 197-209, 2014.","DOI":"10.1016\/j.jhep.2013.07.044"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Teltschik Z, Wiest R, Beisner J, et al. Intestinal bacterial translocation in rats with cirrhosis is related to compromised Paneth cell antimicrobial host defense. Hepatology 55: 1154-1163, 2012.","DOI":"10.1002\/hep.24789"},{"key":"8","unstructured":"8. Moghadamrad S, McCoy KD, Geuking MB, et al. Attenuated portal hypertension in germ-free mice: function of bacterial flora on the development of mesenteric lymphatic and blood vessels. Hepatology 61: 1685-1695, 2015."},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Qin N, Yang F, Li A, et al. Alterations of the human gut microbiome in liver cirrhosis. Nature 513: 59-64, 2014.","DOI":"10.1038\/nature13568"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Lu Y, Chen J, Zheng J, et al. Mucosal adherent bacterial dysbiosis in patients with colorectal adenomas. Sci Rep 6: 26337, 2016.","DOI":"10.1038\/srep26337"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Nagashima K, Hisada T, Sato M, Mochizuki J. Application of new primer-enzyme combinations to terminal restriction fragment length polymorphism profiling of bacterial populations in human feces. Appl Environ Microbiol 69: 1251-1262, 2003.","DOI":"10.1128\/AEM.69.2.1251-1262.2003"},{"key":"12","unstructured":"12. Chavez-Tapia NC, Tellez-Avila FI, Garcia-Leiva J, Valdovinos MA. Use and overuse of proton pump inhibitors in cirrhotic patients. Med Sci Monit 14: CR468-CR472, 2008."},{"key":"13","unstructured":"13. Bajaj JS, Riggio O, Allampati S, et al. Cognitive dysfunction is associated with poor socioeconomic status in patients with cirrhosis: an international multicenter study. Clin Gastroenterol Hepatol 11: 1511-1516, 2013."},{"key":"14","unstructured":"14. Kang SH, Yim HJ, Kim SY, et al. Proton pump inhibitor therapy is associated with reduction of early bleeding risk after prophylactic endoscopic variceal band ligation: a retrospective cohort study. Medicine (Baltimore) 95: e2903, 2016."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Fasullo M, Rau P, Liu DQ, et al. Proton pump inhibitors increase the severity of hepatic encephalopathy in cirrhotic patients. World J Hepatol 11: 522-530, 2019.","DOI":"10.4254\/wjh.v11.i6.522"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Nardelli S, Gioia S, Ridola L, Farcomeni A, Merli M, Riggio O. Proton pump inhibitors are associated with minimal and overt hepatic encephalopathy and increased mortality in patients with cirrhosis. Hepatology 70: 640-649, 2019.","DOI":"10.1002\/hep.30304"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Janka T, Tornai T, Borb\u00e9ly B, et al. Deleterious effect of proton pump inhibitors on the disease course of cirrhosis. Eur J Gastroenterol Hepatol 32: 257-264, 2020.","DOI":"10.1097\/MEG.0000000000001499"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. De Roza MA, Kai L, Kam JW, et al. Proton pump inhibitor use increases mortality and hepatic decompensation in liver cirrhosis. World J Gastroenterol 25: 4933-4944, 2019.","DOI":"10.3748\/wjg.v25.i33.4933"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Okura Y, Namisaki T, Sato S, et al. Proton pump inhibitor therapy does not increase serum endotoxin activity in patients with cirrhosis. Hepatol Res 49: 232-238, 2019.","DOI":"10.1111\/hepr.13249"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Yamamoto K, Ishigami M, Honda T, et al. Influence of proton pump inhibitors on microbiota in chronic liver disease patients. Hepatol Int 13: 234-244, 2019.","DOI":"10.1007\/s12072-019-09932-9"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Tang R, Wei Y, Li Y, et al. Gut microbial profile is altered in primary biliary cholangitis and partially restored after UDCA therapy. Gut 67: 534-541, 2018.","DOI":"10.1136\/gutjnl-2016-313332"},{"key":"22","doi-asserted-by":"publisher","unstructured":"22. Furusawa Y, Obata Y, Fukuda S, et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 504: 446-450, 2013.","DOI":"10.1038\/nature12721"},{"key":"23","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/hep.28356","volume":"63","author":"J Boursier","year":"2016","unstructured":"23. Boursier J, Mueller O, Barret M, et al. The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota. Hepatology 63: 764-775, 2016.","journal-title":"Hepatology","ISSN":"https:\/\/id.crossref.org\/issn\/0270-9139","issn-type":"print"},{"key":"24","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1126\/science.1198469","volume":"331","author":"K Atarashi","year":"2011","unstructured":"24. Atarashi K, Tanoue T, Shima T, et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 331: 337-341, 2011.","journal-title":"Science","ISSN":"https:\/\/id.crossref.org\/issn\/0036-8075","issn-type":"print"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Ohue-Kitano R, Taira S, Watanabe K, et al. 3-(4-hydroxy-3-methoxyphenyl) propionic acid produced from 4-hydroxy-3-methoxycinnamic acid by gut microbiota improves host metabolic condition in diet-induced obese mice. Nutrients 11: E1036, 2019.","DOI":"10.3390\/nu11051036"},{"key":"26","unstructured":"26. Garc\u00eda-S\u00e1nchez JE, Garc\u00eda-S\u00e1nchez E, Garcia-Moro M. The clinical microbiologist before the taxonomic changes in the genus Clostridium. Rev Esp Quimioter 29: 239-243, 2016."},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Chen Y, Yang F, Lu H, et al. Characterization of fecal microbial communities in patients with liver cirrhosis. Hepatology 54: 562-572, 2011.","DOI":"10.1002\/hep.24423"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Peng Y, Shi H, Qi X, et al. The ADH1B Arg47His polymorphism in East Asian populations and expansion of rice domestication in history. BMC Evol Biol 10: 15, 2010.","DOI":"10.1186\/1471-2148-10-15"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Wang W, Chen L, Zhou R, et al. Increased proportions of <i>Bifidobacterium<\/i> and the <i>Lactobacillus<\/i> group and loss of butyrate-producing bacteria in inflammatory bowel disease. J Clin Microbiol 52: 398-406, 2014.","DOI":"10.1128\/JCM.01500-13"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Taur Y, Xavier JB, Lipuma L, et al. Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation. Clin Infect Dis 55: 905-914, 2012.","DOI":"10.1093\/cid\/cis580"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Wahlstr\u00f6m A, Sayin SI, Marschall H-U, B\u00e4ckhed F. Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism. Cell Metab 24: 41-50, 2016.","DOI":"10.1016\/j.cmet.2016.05.005"},{"key":"32","doi-asserted-by":"publisher","unstructured":"32. Leon DA, Saburova L, Tomkins S, et al. Hazardous alcohol drinking and premature mortality in Russia: a population based case-control study. Lancet 369: 2001-2009, 2007.","DOI":"10.1016\/S0140-6736(07)60941-6"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Masip L, Veeravalli K, Georgiou G. The many faces of glutathione in bacteria. Antioxid Redox Signal 8: 753-762, 2006.","DOI":"10.1089\/ars.2006.8.753"},{"key":"34","unstructured":"34. Lovinger DM. Serotonin&apos;s role in alcohol&apos;s effects on the brain. Alcohol Health Res World 21: 114-120, 1997."},{"key":"35","unstructured":"35. Pereg D, Kotliroff A, Gadoth N, Hadary R, Lishner M, Kitay-Cohen Y. Probiotics for patients with compensated liver cirrhosis: a double-blind placebo-controlled study. Nutrition 27: 177-181, 2011."},{"key":"36","doi-asserted-by":"publisher","unstructured":"36. Yoshimoto S, Loo TM, Atarashi K, et al. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature 499: 97-101, 2013.","DOI":"10.1038\/nature12347"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Hayashi H, Beppu T, Okabe H, et al. Combined measurements of serum bile acid level and splenic volume may be useful to noninvasively assess portal venous pressure. J Gastroenterol 47: 1336-1341, 2012.","DOI":"10.1007\/s00535-012-0599-7"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/17\/59_4628-20\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,5]],"date-time":"2020-09-05T03:34:33Z","timestamp":1599276873000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/17\/59_4628-20\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,1]]},"references-count":37,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.4628-20","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,1]]}}}